Allegria Therapeutics was founded in Basel in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that selectively modulate mast cells, Allegria plans to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases.
- http://www.allegriatx.com
- maria.vandongen@allegriatx.com
- Maria van Dongen (CEO)